Drug Shortage Report for ACT METHYLPHENIDATE ER
Report ID | 228143 |
Drug Identification Number | 02441969 |
Brand name | ACT METHYLPHENIDATE ER |
Common or Proper name | METHYLPHENIDATE 54MG ER TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 54MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-05-15 |
Estimated end date | 2024-09-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-06-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-06-07 | French | Compare |
v7 | 2024-06-07 | English | Compare |
v6 | 2024-05-30 | French | Compare |
v5 | 2024-05-30 | English | Compare |
v4 | 2024-05-23 | French | Compare |
v3 | 2024-05-23 | English | Compare |
v2 | 2024-05-16 | French | Compare |
v1 | 2024-05-16 | English | Compare |
Showing 1 to 8 of 8